Merel C. van Maarle

TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands

Karuna R. M. van der Meij, Erik A. Sistermans, Merryn Macville et al. · The American Journal of Human Genetics · 2019 · 374 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Exome sequencing identifies <i>DYNC2H1</i> mutations as a common cause of asphyxiating thoracic dystrophy (Jeune syndrome) without major polydactyly, renal or retinal involvement

Miriam Schmidts, Heleen H. Arts, Ernie M.H.F. Bongers et al. · Journal of Medical Genetics · 2013 · 145 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study

Diane Van Opstal, Merel C. van Maarle, Klaske D. Lichtenbelt et al. · Genetics in Medicine · 2017 · 118 citations · Full text

Life Sciences, Genetics, Obstetrics +17

Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction

Anna M. Bennet, Merel C. van Maarle, Johan Hallqvist et al. · Atherosclerosis · 2005 · 100 citations

Life Sciences, Cardiology, Genetics +16

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study

Lisanne van Prooyen Schuurman, Erik A. Sistermans, Diane Van Opstal et al. · The American Journal of Human Genetics · 2022 · 97 citations · Full text

Medicine, Genetics, Obstetrics +17